Tag: Biotechnology

  October 25, 2022 – Ardigen, a global leader in artificial intelligence for drug discovery, is proud to announce that Agnieszka Blum, MD, PhD has joined the company’s Board of Management. She brings with her extensive knowledge and experience in […]

  March 24, 2022 – Ardigen, a global leader in artificial intelligence for drug discovery, is proud to announce that Lukasz Dutkiewicz, PhD has joined the company as Business Development Director of the Digital CRO division. He brings extensive knowledge […]

Krakow, Poland, 04.11.2021. Ardigen, one of the world’s leading companies that utilizes artificial intelligence (AI) algorithms for drug discovery, announced that another distinguished scientist joined the company’s Scientific Advisory Board. Prof. Olivera Finn will support Ardigen’s work on AI-driven technology […]

Ardigen received funding for development of AI-powered Microbiome Platform that will improve prediction of cancer therapies efficacy. Krakow, Poland, 25.10.2021. Ardigen- the world-leading company that utilizes Artificial Intelligence (AI) for drug discovery, has signed an agreement with the Polish National […]

License from Mid-Atlantic BioTherapeutics for IMT504 Broadens Scope of Initial License Beyond Treatment of Symptomatic Rabies Boca Raton, FL, October 7, 2021 – Curative Biotechnology, Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”) announced today that the Company has reached […]

BioForward’s In-Person Annual Wisconsin Biohealth Summit Celebrates Resilience and Creativity of the Wisconsin Biohealth Industry While Stressing COVID-19 Safety MADISON, Wis– BioForward Wisconsin, the collective voice of Wisconsin’s robust and comprehensive biohealth cluster, representing more than 220 member organizations, is […]

September 7, 2021 – Ardigen, one of the world-leading companies that utilizes artificial intelligence (AI) algorithms for drug discovery, is proud to announce that Dr. Aleksandra Walczak joined the company’s Scientific Council. With a PhD in physical sciences and her […]

Appointment of Independent Director and Chairman of Audit Committee Expands Financial Expertise on Board Boca Raton, FL, July 20, 2021 — Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development stage biomedical company focused on novel therapies […]

Former CNN anchor Brooke Baldwin welcomes an all-star lineup including Albert Bourla, Francis Collins, Jennifer Doudna, Anthony Fauci, Sanjay Gupta, Richard Haass, Janet Woodcock, and a host of industry leaders WASHINGTON (May 3, 2021) –Looking back on a year of […]

Company Appoints Kapil Bharti, Ph.D., and Dimiter Dimitrov, Ph.D. to Scientific and Clinical Advisory Board Boca Raton, FL / iCrowd Newswire/ April 29, 2021 / Curative Biotechnology, Inc.  (OTC: CUBT) a development-stage biomedical company focused on novel therapies for rare diseases, announced today the […]

April 13th, 2021 – Ardigen, a global leader in artificial intelligence for drug discovery, is proud to announce that Guy Cavet, Ph.D. has joined the company’s Advisory Board.  This addition empowers Ardigen to continue expanding its technology and capabilities, and […]

March 11, 2021 – Ardigen, a global leader in artificial intelligence for drug discovery, is proud to announce that Dr. Michał Warchoł has joined the company’s Board of Management as its 4th member. He brings extensive knowledge and experience in the […]

Boca Raton, FL (Feburary 04, 2021) – Connectyx Technologies Holdings Group, Inc. (OTC: CTYX) (“Connectyx” or the “Company”), a development-stage biomedical company focusing on novel treatments for rare diseases today announced it has entered into an Exclusive Patent License Agreement […]

Michigan-based company recognized for the economic and social impact resulting from promoting innovation and helping entrepreneurs through SBIR/STTR funding. CHELSEA, Mich. –– BBCetc announced today that it is one of the recipients of the Tibbetts Awards given by the U.S. Small […]

CHICAGO, IL., October 20, 2020 – Premier issuer-sponsored equity research firm Water Tower Research LLC has published Company Overviews on lithium producers Livent Corporation (NYSE: LTHM) and Galaxy Resources (ASX: GXY) (OTCMKTS: GALXF). These reports focus on each company’s stated strategy, […]

CHICAGO, IL., October 20, 2020  – Water Tower Research has published an Initiation of Coverage Report on CleanSpark (NASDAQ: CLSK). The report focuses on the company’s key drivers, milestones, obstacles and opportunities, and industry megatrends. “The market for microgrids appears to be in a […]

CHICAGO, IL., October 20, 2020  – Water Tower Research has published an Initiation of Coverage Report on Blink Charging (NASDAQ: BLNK). The report focuses on the company’s key drivers, milestones, obstacles and opportunities, and industry megatrends. “Blink operates in the high-growth EV charging market, […]

CHICAGO, IL., October 19, 2020  – Premier issuer-sponsored equity research firm Water Tower Research LLC officially launched coverage of the IT Hardware & Communications Equipment sectors today, including publishing Initiation of Coverage briefs on Cisco Systems (NASDAQ: CSCO), Extreme Networks (NASDAQ: EXTR), and Infinera (NASDAQ: INFN). […]

CHICAGO, IL., October 19, 2020  – Water Tower Research will be hosting Randy MacEwen – Ballard Power’s CEO – in their ongoing Virtual Conference and Fireside Chat Series. The Fireside Chat will take place on Tuesday, October 20th at 1pm […]

Connectyx Technologies Holdings Group, Inc. (OTC: CTYX) (“Connectyx” or the “Company”), a development-stage biomedical company focusing on novel treatments for rare diseases, announced today the Company has signed a definitive agreement with Mid-Atlantic BioTherapeutics, Inc. (MABT) to acquire worldwide rights […]

Wall Street veterans and former colleagues Tim Gerdeman (CEO & Co-Founder) and Shawn Severson (President & Co-Founder) have joined forces to formally launch Water Tower Research LLC as the premier U.S. producer of digitally distributed issuer-sponsored equity research and investor […]